- Report
- December 2022
- 100 Pages
Global
From €2644EUR$2,750USD£2,268GBP
- Report
- March 2023
- 169 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Report
- March 2024
- 150 Pages
From €4990EUR$5,190USD£4,281GBP
- Report
- March 2023
- 185 Pages
Global
From €3063EUR$3,185USD£2,627GBP
€4375EUR$4,550USD£3,753GBP
- Report
- May 2022
- 180 Pages
Global
From €3063EUR$3,185USD£2,627GBP
€4375EUR$4,550USD£3,753GBP
- Report
- April 2021
Global
From €3063EUR$3,185USD£2,627GBP
€4375EUR$4,550USD£3,753GBP
- Report
- June 2022
- 112 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- March 2018
- 116 Pages
Global
From €4087EUR$4,250USD£3,506GBP
- Report
- April 2023
- 80 Pages
Asia Pacific
From €4567EUR$4,750USD£3,918GBP
- Report
- January 2022
- 120 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2020
- 120 Pages
Global
From €4087EUR$4,250USD£3,506GBP
- Report
- October 2023
- 145 Pages
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- August 2022
- 120 Pages
Asia Pacific
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- August 2021
- 220 Pages
Global
From €3063EUR$3,185USD£2,627GBP
€4375EUR$4,550USD£3,753GBP
- Report
- March 2020
- 69 Pages
United States
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- March 2022
- 124 Pages
Global
From €4279EUR$4,450USD£3,671GBP
- Report
- September 2022
- 100 Pages
Global
From €4611EUR$4,795USD£3,955GBP
- Report
- April 2023
- 81 Pages
Middle East, Africa
From €1442EUR$1,500USD£1,237GBP
- Report
- July 2022
- 80 Pages
Middle East, Africa
From €1442EUR$1,500USD£1,237GBP
- Report
- June 2022
- 140 Pages
United States
€13942EUR$14,500USD£11,961GBP
Radiopharmaceuticals are a type of biopharmaceutical used in medical imaging and therapy. They are typically composed of a radioactive isotope, such as technetium-99m, bound to a biologically active molecule, such as a peptide or antibody. Radiopharmaceuticals are used to diagnose and treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. They are administered intravenously, orally, or by inhalation, depending on the type of radiopharmaceutical and the desired therapeutic effect.
The radiopharmaceutical market is a rapidly growing segment of the biopharmaceutical industry. It is driven by advances in medical imaging technology, the development of new radiopharmaceuticals, and the increasing prevalence of diseases that can be treated with radiopharmaceuticals.
Some of the major companies in the radiopharmaceutical market include GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Imaging, and Lantheus Medical Imaging. Show Less Read more